pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells.
about
Recent Developments in Active Tumor Targeted Multifunctional Nanoparticles for Combination Chemotherapy in Cancer Treatment and ImagingCancer nanotheranostics: improving imaging and therapy by targeted delivery across biological barriers.Nanoparticle-mediated systemic delivery of siRNA for treatment of cancers and viral infections.Recent advances in diagnosis and treatment of gliomas using chlorotoxin-based bioconjugates.Superparamagnetic iron oxide nanoparticle-based delivery systems for biotherapeuticsRadiolabeling of poly(lactic-co-glycolic acid) (PLGA) nanoparticles with biotinylated F-18 prosthetic groups and imaging of their delivery to the brain with positron emission tomography.Pathogen-inspired drug delivery to the central nervous system.Cancer cell invasion: treatment and monitoring opportunities in nanomedicine.In vivo multimodal magnetic particle imaging (MPI) with tailored magneto/optical contrast agentsNanoparticle PEGylation for imaging and therapy.Responsive theranostic systems: integration of diagnostic imaging agents and responsive controlled release drug delivery carriers.Grapefruit-Derived Nanovectors Use an Activated Leukocyte Trafficking Pathway to Deliver Therapeutic Agents to Inflammatory Tumor SitesIn vivo delivery, pharmacokinetics, biodistribution and toxicity of iron oxide nanoparticlesNanomaterials as Non-viral siRNA Delivery Agents for Cancer Therapy.N-Alkyl-PEI-functionalized iron oxide nanoclusters for efficient siRNA deliveryRigid nanoparticle-based delivery of anti-cancer siRNA: challenges and opportunities.Surface engineering of iron oxide nanoparticles for targeted cancer therapy.Chlorotoxin-conjugated nanoparticles as potential glioma-targeted drugs.In vivo imaging of the systemic delivery of small interfering RNA.Targeting strategies for multifunctional nanoparticles in cancer imaging and therapy.In vivo gene delivery by nonviral vectors: overcoming hurdles?Multifunctional superparamagnetic iron oxide nanoparticles: design, synthesis and biomedical photonic applications.Tumor-targeting multifunctional nanoparticles for siRNA delivery: recent advances in cancer therapy.Functional nanostructures for effective delivery of small interfering RNA therapeutics.RNAi therapeutics for brain cancer: current advancements in RNAi delivery strategies.Chlorotoxin: Structure, activity, and potential uses in cancer therapy.Imaging-guided delivery of RNAi for anticancer treatment.Stimuli-Responsive Polymeric Nanocarriers for Efficient Gene Delivery.Advances in Peptide Functionalization on Mesoporous Silica Nanoparticles for Controlled Drug Release.Nanoparticle mediated silencing of DNA repair sensitizes pediatric brain tumor cells to γ-irradiation.Self-assembled magnetic theranostic nanoparticles for highly sensitive MRI of minicircle DNA delivery.Multistage pH-responsive liposomes for mitochondrial-targeted anticancer drug delivery.In vivo safety evaluation of polyarginine coated magnetic nanovectors.Polydopamine-Coated Porous Microspheres Conjugated with Immune Stimulators for Enhanced Cytokine Induction in Macrophages.A versatile approach towards multivalent saccharide displays on magnetic nanoparticles and phospholipid vesicles.Nanoparticle-mediated knockdown of DNA repair sensitizes cells to radiotherapy and extends survival in a genetic mouse model of glioblastoma.Engineering functional inorganic-organic hybrid systems: advances in siRNA therapeutics.Shape-, size- and structure-controlled synthesis and biocompatibility of iron oxide nanoparticles for magnetic theranostics.Superparamagnetic Nanoparticles and RNAi-Mediated Gene Silencing: Evolving Class of Cancer Diagnostics and TherapeuticsDevelopment of Magnetic Nanoparticles for Cancer Gene Therapy: A Comprehensive Review
P2860
Q26778234-23AD9178-3929-473B-9CA2-14BA02F8E3E5Q26830028-E36372B3-F799-403B-BD59-C715FAF68DF7Q33935474-7C3217CD-EEE6-4E5D-A69B-D3C256EBBB8FQ34066507-F2209BFC-466C-4018-B063-A895C3741E9CQ34205366-263E360D-5351-4666-B7CD-5E466572E0D3Q34764435-B09D7EBC-3BD1-43DB-A3D0-A66FD2654F47Q34929922-A04F684C-0BF0-4E4B-B953-4A4AD2CD2AD6Q35093966-4FD94F23-8552-4A5E-ADC4-196F0CB60B43Q35232459-9111B841-44BF-4A1B-86EC-45527EAB86C1Q35553193-5B08BE3E-9EC1-400D-A9C4-13AAE8E34C08Q35558487-5788A5CA-1362-4D8D-8050-B19955A735C6Q35751910-BADF2084-449A-4A57-8CA2-E4ACDB80FD67Q36289257-AA53AF63-6131-4800-9E7D-2B17C71B9C59Q37020672-F91322A7-EE4F-4562-9677-C38415C7C789Q37137333-0A77A902-CDF7-440A-8B7D-38BBE31F6428Q37626377-579225B6-B162-419A-BAA4-67AC052EFAD9Q37870178-F81C6088-B3AE-4769-947A-379678B896C5Q37959770-071CB685-58F4-4690-9CFE-7788FA446032Q37974175-98AF00E7-6F00-428B-A645-9654A36A3FF0Q37978315-CD89F3BD-699A-4F31-937A-3F09DDEF77C4Q38004708-E43BA068-D1BF-495E-A090-E7966173983BQ38123354-9F56554C-05D3-4830-BAEC-C4836CFCD11BQ38191832-9FB317DA-8585-4ECA-BF25-4C8AA7B9D479Q38256970-7F1A3419-1121-49DC-8A8D-52C91995D932Q38541950-56F1628F-5E4B-4967-8F94-111542768EEDQ38595154-37A12023-A010-4C6E-8EEE-36AB72F2B866Q38710046-EFC5E75C-F2C8-44B0-AEDE-BDB199B70EE6Q38757883-E10991A8-3BDC-47B3-8541-9D3A17B9A43CQ38827516-B2443537-F92F-4662-A513-0068D01ADC6AQ38909841-37DA9BD1-A117-410C-801B-021655E94415Q39229853-DA8F80E3-20BF-45D3-8222-4E51B7AE2000Q39334978-82F86C2A-5BE3-4FFA-9CC0-06A211FF624EQ42117571-9AFC220E-5044-40B4-904E-CB67EE114700Q42808314-3451DF20-8172-488F-ACE9-44A5E1FB44DBQ42823044-B935621F-4B86-4713-90C5-2EAB3446A9FDQ48018806-60D9A900-0F02-4115-90AF-D460BEABC734Q50123721-2A94B5E4-E3EB-46B9-B8CA-55863279F8FEQ55450179-664CB39C-9FF4-4627-AB14-B31EA692ED4EQ58909203-2E5EAD72-20F7-439E-A0A9-8E3B22A8BD57Q58998029-222EF480-2C10-4DDE-9F29-7752E4BEA035
P2860
pH-Sensitive siRNA nanovector for targeted gene silencing and cytotoxic effect in cancer cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.
@ast
pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.
@en
pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.
@nl
type
label
pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.
@ast
pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.
@en
pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.
@nl
prefLabel
pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.
@ast
pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.
@en
pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.
@nl
P2093
P2860
P356
P1476
pH-Sensitive siRNA nanovector ...... otoxic effect in cancer cells.
@en
P2093
Forrest M Kievit
Freddy Y Wang
Hyejung Mok
James O Park
Miqin Zhang
Omid Veiseh
P2860
P304
P356
10.1021/MP100221H
P407
P577
2010-09-14T00:00:00Z